Company has already procured land for further expanding its existing Metformin capacity to 3,000 TPM in a brownfield expansion
The company already has an existing R&D center in Gurgaon for generation of scientific data and evaluation of new molecules.
The Fine & Specialty Chemicals (FSC) segment delivered a stellar performance with revenue growth of 52% y-o-y.
The Group increased sales to $5.4 billion, which is 5 percent higher compared to the same period last year while EBITDA increased by 1 percent to $733 million.
The company has achieved this significant growth due to large quantities of Dichloro Diphenyl Trichloroethane (DDT) and agrochemicals shipped to Southern African countries, Latin America and Iran during the period.
Revenue for Q2 FY21 stood at Rs. 509.34 million which grew by 19.4% as compared to Q2 FY20.
Company has registered a drop of 16% in Q3 operating profit to CHF 127 million ($140 million), with the profit margin narrowing to 14.2% from 14.5%.
Company has posted a growth of 16.47% YoY with a total income of Rs.328.57 crores
The jump in profit is due to the fact that PI Industries witnessed 25 per cdbt increase in exports and 33 per cent rise in domestic revenue.
Company reported consolidated income of Rs. 2,609 crore in Q2 FY21, up by 11% as compared to Rs. 2,348 crore last year.
Company's gross profit grew by 51.5% YoY to Rs.132 crore in Q2 FY21.
The company has made investments of about Rs. 105 crore in its 90 acre greenfield project, out of the total capex of Rs. 150 crore and is expecting to commence manufacturing of Ethylamines by the end of the last quarter of this financial year.
The new state-of-the-art preservation system for the Cosmenyl 100 range does not contain ortho-phenylphenol (O-PP), methylisothiazolinone (MIT) or parabens.
As per the agreement, Piramal Pharma will buy 49% stake of Navin Fluorine Rs. 65.10 crore thus becoming 100% owner of CCPL.
The company listed on the BSE SME platform over two years back and has met all the criteria needed for the shift.
A new cellulase, Lavergy C Bright 100 L, in combination with BASF Home Care and I&I ingredients promises dazzling results both for cotton and synthetic fabrics.
For the period, the company has reported total income of Rs.86.37 crores as compared to Rs.48.90 crores during the period ended June 30, 2020.
Revenue for Q2 FY 21 was down by 1.6% to reach Rs. 250.52 crore vis-a-vis Rs. 254.41 crore in Q2 FY20.
For the full year 2020, the BASF expects a slight decline in sales compared with the previous year, mainly due to weaker demand as a consequence of the coronavirus pandemic.
Company has earmarked an aggressive capex plan for capacity addition for growth projects largely in margin accretive HPP and specialty segments.
Subscribe To Our Newsletter & Stay Updated
